Canada Life’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,241
| Closed | -$948K | – | 2168 |
|
|
2023
Q4 | $948K | Buy |
16,241
+11,436
| +238% | +$668K | ﹤0.01% | 1520 |
|
|
2023
Q3 | $209K | Buy |
4,805
+1,860
| +63% | +$80.9K | ﹤0.01% | 1849 |
|
|
2023
Q2 | $107K | Buy |
2,945
+701
| +31% | +$25.5K | ﹤0.01% | 1920 |
|
|
2023
Q1 | $84K | Buy |
2,244
+121
| +6% | +$4.53K | ﹤0.01% | 1999 |
|
|
2022
Q4 | $97K | Buy |
2,123
+49
| +2% | +$2.24K | ﹤0.01% | 1990 |
|
|
2022
Q3 | $145K | Buy |
2,074
+32
| +2% | +$2.24K | ﹤0.01% | 1925 |
|
|
2022
Q2 | $137K | Buy |
2,042
+30
| +1% | +$2.01K | ﹤0.01% | 1875 |
|
|
2022
Q1 | $176K | Sell |
2,012
-53
| -3% | -$4.64K | ﹤0.01% | 1898 |
|
|
2021
Q4 | $302K | Buy |
2,065
+30
| +1% | +$4.39K | ﹤0.01% | 1803 |
|
|
2021
Q3 | $362K | Hold |
2,035
| – | – | ﹤0.01% | 1787 |
|
|
2021
Q2 | $329K | Sell |
2,035
-187
| -8% | -$30.2K | ﹤0.01% | 1827 |
|
|
2021
Q1 | $378K | Buy |
2,222
+105
| +5% | +$17.9K | ﹤0.01% | 1802 |
|
|
2020
Q4 | $464K | Hold |
2,117
| – | – | ﹤0.01% | 1766 |
|
|
2020
Q3 | $351K | Hold |
2,117
| – | – | ﹤0.01% | 1772 |
|
|
2020
Q2 | $240K | Buy |
2,117
+354
| +20% | +$40.1K | ﹤0.01% | 1871 |
|
|
2020
Q1 | $137K | Hold |
1,763
| – | – | ﹤0.01% | 1910 |
|
|
2019
Q4 | $226K | Buy |
+1,763
| New | +$226K | ﹤0.01% | 1901 |
|
|
2019
Q3 | – | Sell |
-3,130
| Closed | -$322K | – | 2425 |
|
|
2019
Q2 | $322K | Hold |
3,130
| – | – | ﹤0.01% | 1910 |
|
|
2019
Q1 | $229K | Buy |
3,130
+1,149
| +58% | +$84.1K | ﹤0.01% | 1843 |
|
|
2018
Q4 | $81K | Hold |
1,981
| – | – | ﹤0.01% | 2218 |
|
|
2018
Q3 | $93K | Hold |
1,981
| – | – | ﹤0.01% | 2216 |
|
|
2018
Q2 | $97K | Buy |
+1,981
| New | +$97K | ﹤0.01% | 2192 |
|